Manufacturer record
Alembic Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Alembic Pharmaceuticals Ltd (Sikkim) were declared Not of Standard Quality between February 2021 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 2408001232, Azithromycin Tablets IP 500 mg (exp Sep 2026). SDTL, Guwhati, Assam (state lab) found it not of standard quality: The sample does not conform to I.P. w.r.to the tests for Identification and Assay. Listed in the August 2026 alert.
Records by type
3 records linked to Alembic Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Azithromycin Tablets IP 500 mg | Batch 2408001232Mfg Oct 2024 · Exp Sep 2026 | The sample does not conform to I.P. w.r.to the tests for Identification and AssayAssay | SDTL, Guwhati, AssamState lab | Aug 2026 |
| Telmisartan Tablets IP 40 mg | Batch 2513000079Mfg Aug 2025 · Exp Aug 2027 | The sample does not conform to I.P. w.r.to the tests for Dissolution & AssayAssay | SDTL, AssamState lab | Apr 2026 |
| ULGEL ? A 200 ml (Magaldrate, Simethicone & Oxetacaine Oral Suspension) | Batch 1808001807Mfg Dec 2018 · Exp Nov 2021 | Assay of OxetacaineAssay | CDL KolkataCDSCO lab | Feb 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.